World's top Pharmaceuticals stocks
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
LLYEli Lilly and Co | $698.52bn | 66.31 | 0.64% |
NOVO BNovo Nordisk A/S | DKK3.75tn | 44.78 | 1.11% |
JNJ WDJohnson & Johnson | $397.54bn | 20.6 | 2.81% |
JNJJohnson & Johnson | $359.25bn | 16 | 3.19% |
MRKMerck & Co | $322.99bn | 57.74 | 2.35% |
ABBVAbbvie | $290.01bn | 36.06 | 3.61% |
AZNAstraZeneca | £186.80bn | 48.34 | 1.92% |
ROGRoche Holding AG | CH₣173.24bn | 12.08 | 4.42% |
RORoche Holding AG | CH₣173.24bn | 13.09 | 4.07% |
NOVNNovartis AG | CH₣172.11bn | 16.97 | 4.04% |
AMGNAmgen | $166.97bn | 40.68 | 2.78% |
PFEPfizer | $157.48bn | 9.92 | 5.93% |
SANSanofi SA | €114.25bn | 17.28 | 4.12% |
GSKGSK | £71.85bn | 13.72 | 3.4% |
CELG RTBristol-Myers Squibb Co | $89.17bn | 0.01 | 4358.49% |
BMYBristol-Myers Squibb Co | $89.17bn | 11.73 | 5.25% |
CSLCSL | AU$133.24bn | 34.18 | 1.42% |
GILDGilead Sciences | $80.72bn | 11.61 | 4.66% |
ZTSZoetis | $76.23bn | 31.89 | 0.93% |
MRKMerck KGaA | €66.09bn | 19.82 | 1.45% |